
Sign up to save your podcasts
Or


What happens when the biology is strong but the market turns against you? In this week’s episode, we break down the Q1 2025 earnings from publicly traded salmon producers across six countries. While fish health remains solid, companies are facing some of the lowest salmon prices in recent memory, dragging down profits, shaking up leadership, and forcing a rethink of what “profitable farming” really means. We dive into EBIT/kg performance across the board, spotlight standout results from Grieg and Salmones Camanchaca, and unpack why Iceland and Canada are at a strategic crossroads.
Download our report for Q1 of 2025.
For more aquaculture insights head to our Fish n’ Bits blog.
By Manolin5
66 ratings
What happens when the biology is strong but the market turns against you? In this week’s episode, we break down the Q1 2025 earnings from publicly traded salmon producers across six countries. While fish health remains solid, companies are facing some of the lowest salmon prices in recent memory, dragging down profits, shaking up leadership, and forcing a rethink of what “profitable farming” really means. We dive into EBIT/kg performance across the board, spotlight standout results from Grieg and Salmones Camanchaca, and unpack why Iceland and Canada are at a strategic crossroads.
Download our report for Q1 of 2025.
For more aquaculture insights head to our Fish n’ Bits blog.

31,989 Listeners

12 Listeners

30,187 Listeners

19 Listeners

16 Listeners

98 Listeners

2 Listeners

0 Listeners

0 Listeners